Eun Young Choi

Eun Young Choi

Auto-generated profile, based on publicly available information

Eun Young Choi

Department of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
DRDerry C. Roopenian
Derry C. Roopenian
GCGregory J. Christianson
Gregory J. Christianson
TSThomas J. Sproule
Thomas J. Sproule
ABAaron C. Brown
Aaron C. Brown
SAShreeram Akilesh
Shreeram Akilesh
CAClark L. Anderson
Clark L. Anderson
Abs of the IgG isotype are efficiently transported from mother to neonate and have an extended serum t1/2 compared with Abs of other isotypes. Circumstantial evidence suggests that the MHC class I-related protein, the neonatal FcR (FcRn), is the FcR responsible for both in vivo functions. To understand the phenotypes imposed by FcRn, we produced and analyzed mice with a defective FcRn gene. The results provide direct evidence that perinatal IgG transport and protection of IgG from catabolism are mediated by FcRn, and that the latter function is key to IgG homeostasis, essential for generating a potent IgG response to foreign Ags, and the basis of enhanced efficacy of Fc-IgG-based therapeutics. FcRn is therefore a promising therapeutic target for enhancing protective humoral immunity, treating autoimmune disease, and improving drug efficacy.

20 December 2002 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
DRDerry Roopenian
Derry Roopenian
ECEun Young Choi
Eun Young Choi
ABAaron Brown
Aaron Brown

1 October 2005 in Immunity
Verified
Journal Article
Closed access
ECEun Young Choi
Eun Young Choi
KJKyeong Cheon Jung
Kyeong Cheon Jung
HPHyo Jin Park
Hyo Jin Park
DCDoo Hyun Chung
Doo Hyun Chung
JSJin Sook Song
Jin Sook Song
SPSeong Hoe Park
Seong Hoe Park

27 November 2015 in Scientific Reports
Verified
Journal Article
Open access
WSWoo-Jeong Shon
Woo-Jeong Shon
YLYoung-Kwan Lee
Young-Kwan Lee
JSJi Hee Shin
Ji Hee Shin
ECEun Young Choi
Eun Young Choi
Dong-Mi ShinDong-Mi Shin
Dong-Mi Shin
Indoleamine 2,3 -dioxygenase 1 (IDO1) catalyzes L-tryptophan to kynurenine in the first and rate-limiting step of tryptophan metabolism. IDO1 is expressed widely throughout the body, with especially high expression in colonic intestinal tissues. To examine the role of IDO1 in the colon, transcriptome analysis was performed in both Ido1−/− and Ido1+/+ mice. Gene set enrichment analysis identified the Inflammatory Response as the most significant category modulated by the absence of IDO1. This observation prompted us to further investigate the function of IDO1 in the development of tissue inflammation. By using DSS-induced experimental colitis mice models, we found that the disease in Ido1−/− mice was less severe than in Ido1+/+ mice. Pharmacological inhibition of IDO1 by L-1MT attenuated the severity of DSS-colitis as well. Transcriptome analyses revealed that pathways involving TLR and NF-kB signaling were significantly down-regulated by the absence of IDO1. Furthermore, dramatic changes in TLR and NF-kB signaling resulted in substantial changes in the expression of many inflammatory cytokines and chemokines. Numbers of inflammatory cells in colon and peripheral blood were reduced in IDO1 deficiency. These findings suggest that IDO1 plays important roles in producing inflammatory responses and modulating transcriptional networks during the development of colitis.

1 November 2002 in Immunity
Verified
Journal Article
Closed access
ECEun Young Choi
Eun Young Choi
GCGregory J Christianson
Gregory J Christianson
YYYoshitaka Yoshimura
Yoshitaka Yoshimura
TSThomas J Sproule
Thomas J Sproule
NJNadja Jung
Nadja Jung
DRDerry C Roopenian
Derry C Roopenian

1 April 2001 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ECEun Young Choi
Eun Young Choi
YYYoshitaka Yoshimura
Yoshitaka Yoshimura
GCGregory J. Christianson
Gregory J. Christianson
TSThomas J. Sproule
Thomas J. Sproule
SMSubramaniam Malarkannan
Subramaniam Malarkannan
DRDerry C. Roopenian
Derry C. Roopenian
Minor histocompatibility Ags (minor H Ags) are substantial impediments to MHC-matched solid tissue and bone marrow transplantation. From an antigenic standpoint, transplantation between MHC-matched individuals has the potential to be remarkably complex. To determine the extent to which the immune response is simplified by the phenomenon of immunodominance, we used peptide/MHC tetramers based on recently discovered minor H Ags (H60, H13, and HY) and monitored in vivo CD8 T cell responses of female C57BL/6 mice primed with MHC-matched, but background-disparate, male BALB.B cells. CD8 T cells against H60 overwhelmed responses to the H13 and HY throughout primary and secondary challenge. H60 immunodominance was an inherent quality, overcoming a lower memory precursor frequency compared with that of H13 and evoking a T cell response with diverse TCRVβ usage. IFN-γ staining examining congenically defined minor H Ags extended H60 dominance over additional minor H Ags, H28, H4, and H7. These four minor H Ags accounted for up to 85% of the CD8 T cell response, but H60 stood out as the major contributor. These findings show that immunodominance applies to antigenically complex transplantation settings in vivo and that the responses to the H60 minor H Ag dominates in this model. We suggest that immunodominant minor H Ags are those that result from the absence of a self analog.